The immunological deficiency state in ataxia-telangiectasia.
D000917:Antibody Formation; D001260:Ataxia Telangiectasia / Q000276:immunology*; D002531:Cerebellum / Q000473:pathology; D003711:Demyelinating Diseases; D004926:Escherichia coli / Q000276:immunology; D005455:Fluorescent Antibody Technique; D005910:Glioma / Q000150:complications; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007114:Immunization; D007136:Immunoglobulins / Q000032:analysis; D007153:Immunologic Deficiency Syndromes / Q000276:immunology*; D008213:Lymphocyte Activation; D008221:Lymphoid Tissue / Q000276:immunology; D008527:Medulloblastoma / Q000150:complications; D009132:Muscles / Q000473:pathology; D009461:Neurologic Manifestations; D012463:Saliva / Q000276:immunology; D016038:Skin Transplantation; D013116:Spinal Cord / Q000473:pathology; D013950:Thymus Gland / Q000473:pathology; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D007136:Immunoglobulins